FOXM1 and prostate cancer: An increase of expression of FoxM1 is associated with the development and progression of many cancers, including breast, liver, prostate, brain, and lung cancers, whereas the ectopic expression of the FoxM1 accelerated the development, proliferation, and tumor growth in mouse models of prostate cancer 40.